Nurix Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Nurix Therapeutics's balance sheet done over the years? Its assets were worth $355,598,000 last year, which is less than in the previous period. 44% of Nurix Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $155,105,000, which means an increase by 37% compared compared to last year.

Debt to Assets

Nurix Therapeutics, Inc. (NASDAQ:NRIX): Debt to assets
2018 45397000 82.24M 181.17%
2019 44048000 101.76M 231.03%
2020 396343000 106.07M 26.76%
2021 476771000 134.46M 28.2%
2022 416759000 113.06M 27.13%
2023 355598000 155.10M 43.62%

NRIX Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
54.62M64.47M80.50M119.35M34.81M25.59M
Short term investments
233.28M244.66M215.21M161.79M2.90M13.44M
Net receivables
01.1M6.20M11.34M00
Inventory
0-1.1M1000
Other current assets
7.59M9.30M9.19M5.94M1.63M1.61M
Total current assets
295.50M318.44M311.11M298.43M39.35M40.65M
Non-current assets:
Property, Plant and Equipment
47.95M29.50M25.34M6.67M3.87M4.42M
Goodwill
000000
Intangible assets
000000
Long term investments
7.42M63.87M137.18M90.89M506K0
Other non-current assets
4.72M4.92M3.11M347K317K321K
Total non-current assets
60.09M98.31M165.65M97.90M4.69M4.74M
Total assets
355.59M416.75M476.77M396.34M44.04M45.39M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
48.09M37.63M41.21M32.79M9.61M28.42M
Short term debt
13.90M5.53M3.84M7.62M4.61M2.83M
Total current liabilities
86.95M70.65M66.25M44.53M16.13M32.83M
Non-current liabilities:
Long term debt
23.12M6.43M9.18M000
Deferred tax
000000
Other non-current liabilities
0-3.30M-3.32M850K49.93M49.41M
Total non-current liabilities
68.14M42.40M68.21M61.53M85.62M49.41M
Total liabilities
155.10M113.06M134.46M106.07M101.76M82.24M
Data sourceData sourceData sourceData source